Cantor Fitzgerald LP’s lawsuit alleging a firm founded by four of its former investment bankers stole clients worth millions of dollars in profit was dismissed by a New York judge.
Cantor Fitzgerald upgraded Lam Research (LRCX) to Overweight from Neutral with a price target of $100, up from $95. The firm had suggested ...
Fintel on MSN1d
Cantor Fitzgerald Upgrades Beam Therapeutics (BEAM)Fintel reports that on January 29, 2025, Cantor Fitzgerald upgraded their outlook for Beam Therapeutics (NasdaqGS:BEAM) from ...
Donald Trump's commerce secretary nominee told his US Senate confirmation hearing Wednesday he favors "across-the-board" tariffs targeting countries rather than products, while signaling a hawkish ...
Donald Trump's commerce secretary nominee said Wednesday that he favors "across-the-board" tariffs and a country-based ...
In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, ...
‘Survivor’: Michele Fitzgerald Defends ‘Controversial’ Season 32 Win Against Critics (VIDEO)
For exclusive news and updates, subscribe to our Survivor Newsletter: It’s been nearly 10 years since Michele Fitzgerald was crowned the winner of Survivor Season 32, but she’s still haunted ...
In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on PTC Therapeutics (PTCT – Research Report), with a price target of $76.00. The company’s shares ...
On Wednesday, Cantor Fitzgerald analysts maintained an Overweight rating on Applied Blockchain Inc (NASDAQ: APLD) stock. The revision follows Applied Digital Corp.'s disclosure of its second ...
It is based on F Scott Fitzgerald’s 1922 short story, and shares a premise: Benjamin Button (John Dagliesh) is a man inexplicably born at the age of 70, who then begins to age backwards ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback